Focus: Progyny is a women's health company focused on IVF products and infertility treatment solutions, headquartered in New York with a specialized biotech footprint.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Strong fit for commercial, business development, and legal talent seeking a mission-driven women's health play with near-term revenue scaling; caution for R&D-focused scientists due to opaque pipeline maturity and limited scientific publication footprint.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core IVF diagnostic product with multiple ongoing clinical and usability studies supporting market penetration and clinical adoption.
Help build intelligence for Progyny
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Progyny's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Progyny (PGNY) Stock: Trendline Structure Analysis (+2.83%) 2026-04-27 - Insider Selling - Newser
Progyny (PGNY) Stock: Trendline Structure Analysis (+2.83%) 2026-04-27 - Insider Selling Newser
KeyBanc Names Top Healthcare Stocks - Investing.com UK
KeyBanc Names Top Healthcare Stocks Investing.com UK
KeyBanc Names Top Healthcare Stocks - Investing.com
KeyBanc Names Top Healthcare Stocks Investing.com
Progyny Inc stock (US74340E1038): Is fertility benefits demand strong enough to drive sustained grow - AD HOC NEWS
Progyny Inc stock (US74340E1038): Is fertility benefits demand strong enough to drive sustained grow AD HOC NEWS
Progyny Inc stock (US74340E1038): Is fertility benefits expansion the key growth driver for U.S. inv - AD HOC NEWS
Progyny Inc stock (US74340E1038): Is fertility benefits expansion the key growth driver for U.S. inv AD HOC NEWS
From 5 employers to 600: Progyny marks 10 years in family care - Stock Titan
From 5 employers to 600: Progyny marks 10 years in family care Stock Titan
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo